Non-alcoholic fatty liver disease (NAFLD) has become the leading cause of chronic liver
diseases worldwide, causing considerable liver-related mortality and morbidity. During the …

Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease
in Western countries and is also predicted to become the most frequent indication for liver …

Non‐alcoholic fatty liver disease (NAFLD) affects a substantial proportion of the general
population and is frequently associated with many features of the metabolic syndrome …

Nonalcoholic fatty liver disease (NAFLD) has become the most prevalent liver disease in
western society and is increasing in parallel with the worldwide epidemic of obesity. It exists …

Nonalcoholic fatty liver disease (NAFLD) is a prevalent disease with 20–30% of the
population affected in many developed and developing countries. Studies assessing the …

Overwhelming evidence suggests an association of cardiovascular disease (CVD) with non-
alcoholic fatty liver disease (NAFLD); however, the underlying mechanisms remain largely …

Context: Nonalcoholic fatty liver disease (NAFLD) is increasingly diagnosed worldwide and
is the most common chronic liver disease in Western countries. In this review, we discuss the …

Nonalcoholic fatty liver disease (NAFLD) is a common, progressive liver disease that affects
up to one-quarter of the adult population worldwide. The clinical and economic burden of …

Non-alcoholic fatty liver disease (NAFLD) encompasses pure steatosis through nonalcoholic
steatohepatitis (NASH) and is the most common cause of chronic liver disease in Western …

Background Studies have reported a significant association between non-alcoholic fatty liver
disease (NAFLD) and increased incidence of cardiovascular disease (CVD). However, the …